Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis. Goring, S, Hawkins, N, Wygant, G, Roudaut, M, Townsend, R, Wood, I, & Barnett, A. Diabetes, Obesity and Metabolism, 16(5):433–442, 2014.
bibtex   
@article{goring_dapagliflozin_2014,
	title = {Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis},
	volume = {16},
	number = {5},
	journal = {Diabetes, Obesity and Metabolism},
	author = {Goring, S and Hawkins, N and Wygant, G and Roudaut, M and Townsend, R and Wood, I and Barnett, AH},
	year = {2014},
	keywords = {Administration, Oral, Benzhydryl Compounds, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Drug Therapy, Combination, Female, Glucosides, Glycated Hemoglobin A, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Metformin, Middle Aged, Randomized Controlled Trials as Topic, SGLT2 inhibitor, Sulfonylurea Compounds, Thiazolidinediones, Treatment Outcome, meta-analysis, metformin, type 2 diabetes},
	pages = {433--442},
}

Downloads: 0